Patents by Inventor Mao Lin Hsu

Mao Lin Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7371524
    Abstract: The present invention relates to marker components, fluorescent probes, oligonucleotides, hybridization assays, and immunoassays using such products, and methods for making such products. According to the present invention, detectably labeled marker components are provided that comprise a fluorescent moiety coupled to two small solubilizing groups, one on each side of the molecular plane, said fluorescent moiety having substituents to control net charge so as to reduce or remove the problems of solvent sensitivity and nonspecific binding.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: May 13, 2008
    Inventors: Walter B. Dandliker, Mao Lin Hsu, William P. Murphy, Jr.
  • Patent number: 5919922
    Abstract: Fluorescent dyes which are free of aggregation and serum binding are provided. These dyes are suitable for applications such as fluorescence immunoassays, in vivo imaging and in vivo tumor therapy.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: July 6, 1999
    Assignee: Hyperion, Inc.
    Inventors: Walter Beach Dandliker, Mao-Lin Hsu
  • Patent number: 5880287
    Abstract: Fluorescent dyes which are free of aggregation and serum binding are provided. These dyes are suitable for applications such as fluorescence immunoassays, in vivo imaging and in vivo tumor therapy. Fluorescence immunoassays methods are provided which use fluorescent dyes which are free of aggregation and serum binding. Such immunoassay methods are thus, particularly useful for the assay of biological fluids, such as serum, plasma, whole blood and urine. The present invention is directed to compositions comprising an oligonucleotide linked to a detectably labeled marker component comprising a fluorophore moiety which comprises a substantially planar, multidentate macrocyclic ligand coordinated to a central atom capable of coordinating with two axial ligands and two polyoxyhydrocarbyl moieties which are attached as axial ligands to the central atom. The present invention is also directed to nucleic acid hybridization and amplification methods employing such compositions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 9, 1999
    Assignee: Hyperion, Inc.
    Inventors: Walter B. Dandliker, Robert Francis Devlin, Peter Olaf Gustaf Arrhenius, Mao-Lin Hsu
  • Patent number: 5641878
    Abstract: Fluorescent dyes which are free of aggregation and serum binding are provided. These dyes are suitable for applications such as fluorescence immunoassays, in vivo imaging and in vivo tumor therapy. The dyes are particularly useful in fluorescence immunoassays of biological samples containing serum. Such dyes have two polyoxyhydrocarbyl moities, one located on either side of a planar molecular structure such as a porphyrin derivative, azaporphyrin derivative, corrin derivative, sapphyrin derivative or porphycene derivative.
    Type: Grant
    Filed: November 2, 1994
    Date of Patent: June 24, 1997
    Assignee: Diatron Corporation
    Inventors: Walter B. Dandliker, Mao-Lin Hsu